Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Covance and sanofi-aventis enter 10-year strategic collaboration

Nov. 3, 2010

Compugen licenses MAb-based oncology target to Seattle Genetics

Nov. 3, 2010

GSK and Amicus to develop Amigal for Fabry's disease

Nov. 2, 2010

Acadia enters agreement with Biovail to regain rights to pimavanserin

Nov. 2, 2010

AstraZeneca and Daiichi Sankyo announce agreement to copromote Nexium in Japan

Nov. 2, 2010

Biotie and Roche to terminate research and option agreement for SSAO inhibitors

Oct. 29, 2010

Evotec licenses EVT-201 to Jingxin Pharma

Oct. 29, 2010

Nascobal to be commercialized outside U.S. for vitamin B12 deficiency

Oct. 28, 2010

MacroGenics and Pfizer enter into DART collaboration and license agreement

Oct. 28, 2010

Evotec and Apeiron Biologics collaborate on DREAM modulators for pain

Oct. 28, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...